AR and Familial prostate cancer: AR physically interacts with β-catenin and uses β-catenin as a co-factor to amplify the transcription of AR target genes in prostate cancer, thereby competitively inhibiting TCF/LEF-mediated transcription of β-catenin target genes (Figure 2C) (6, 46).